Oncology Institute (TOI) Invested Capital: 2020-2025
Historic Invested Capital for Oncology Institute (TOI) over the last 6 years, with Q3 2025 value amounting to $63.9 million.
- Oncology Institute's Invested Capital fell 4027.14% to $63.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $63.9 million, marking a year-over-year decrease of 4027.14%. This contributed to the annual value of $96.7 million for FY2024, which is 3276.38% down from last year.
- As of Q3 2025, Oncology Institute's Invested Capital stood at $63.9 million, which was down 4027.14% from $66.0 million recorded in Q2 2025.
- Oncology Institute's 5-year Invested Capital high stood at $207.0 million for Q3 2022, and its period low was $47.1 million during Q1 2021.
- Its 5-year average for Invested Capital is $117.2 million, with a median of $119.2 million in 2024.
- Its Invested Capital has fluctuated over the past 5 years, first skyrocketed by 38621.83% in 2021, then crashed by 4457.85% in 2025.
- Quarter analysis of 5 years shows Oncology Institute's Invested Capital stood at $104.2 million in 2021, then surged by 95.66% to $203.8 million in 2022, then fell by 29.41% to $143.9 million in 2023, then tumbled by 32.76% to $96.7 million in 2024, then plummeted by 33.91% to $63.9 million in 2025.
- Its Invested Capital stands at $63.9 million for Q3 2025, versus $66.0 million for Q2 2025 and $79.0 million for Q1 2025.